Selected Publications:
Kim A. Reiss, MD; Rosemarie Mick, MS; Mark O’Hara, MD; Ursina Teitelbaum, MD; Thomas Karasic, MD; Charles Schneider, MD; Peter O’Dwyer, MD; Danielle Karlson, RN; Stacy Cowden, RN; Mary Jane Fuhrer, BA; Erica Carpenter, PhD; Austin Pantel, MD; Mehran Makvandi, PharmD; David Mankoff, MD, PhD; Katharine Nathanson, MD; Kara Maxwell, MD, PhD; Gregory Beatty, MD, PhD; Susan Domchek, MD: A Randomized Phase II Trial of Niraparib Plus Either Nivolumab or Ipilimumab in Patients with Platinum Sensitive, Advanced Pancreatic Cancer
ASCO Annual Meeting, Chicago, IL : 2019.
Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.: Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent? Molecular and Clinical Oncology : 2019.
Thomas B. Karasic, MD; Mark O'Hara, MD; Arturo Loaiza-Bonilla, MD; Kim A. Reiss, MD; Ursina R. Teitelbaum, MD; Erkut Borazanci, MD; Ana De Jesus-Acosta, MD; Colleen Redlinger, BA; Jessica A. Burrell, BA; Daniel A. Laheru, MD; Daniel D. Von Hoff, MD; Ravi K. Amaravadi, MD; Jeffrey A. Drebin, MD, PhD; Peter J. O’Dwyer, MD: Randomized Phase II Trial of Gemcitabine and 'nab-Paclitaxel With or Without Hydroxychloroquine in Advanced Pancreatic Cancer JAMA Oncology : 2019.
Stéphanie L. Gaillard, MD, PhD; Marianna Zahurak; Anup Sharma; Kim Reiss, MD; Susan Sartorius; Melinda Downs; Nicole M. Anders; Nita Ahuja, MD; Michelle A. Rudek, PhD1; Nilofer Azad, MD: A phase I trial of oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors Cancer : 2019.
Kim A. Reiss Binder, Rosemarie Mick, Mark O'Hara, Ursina Teitelbaum, Thomas Karasic, Charles Schneider, Peter J. O'Dwyer, Erica Carpenter, Austin Pantel, Mehran Makvandi, David Mankoff, Katherine Nathanson, Kara Maxwell, Stacy Cowden, Mary Jane Fuhrer, Janae Romeo, Gregory L. Beatty, Susan, Domchek.: A Phase II, Single Arm Study of Maintenance Rucaparib in Patients with Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or
Somatic Mutation in BRCA1, BRCA2 or PALB2 AACR Annual Meeting, Atlanta GA : 2019.
Shivaani Kummar, Shuli Li, Kim A Reiss, James M Ford, Edith P. Mitchell, Lisa M. McShane, Robert J. Gray, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Peter J. O'Dwyer, Lyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty: NCI-MATCH EAY131 –Z1I: Phase II Study of AZD1775, a Wee-1 kinase inhibitor, in Patients with Tumors Containing BRCA1 and BRCA2 Mutations AACR Annual Meeting, Atlanta, GA : 2019.
Brittany Bauman, Rosemarie Mick, Eileen Martinez, Theresa Lawless, Lindsey Zinck, Paige Madison, Mary Fuhrer, Mark O’Hara, Charles Schneider, Peter O’Dwyer, John Plastaras, Ursina Teitelbaum, and Kim A. Reiss: Efficacy of oral cryotherapy during oxaliplatin infusion in preventing oral thermal hyperalgesia: A randomized trial JNCCN : 2019.
Shun Yu; Parul Agarwal; Ronac Mamtani; Heather Symecko; Kelsey Spielman; Mark O’Hara; Peter J. O’Dwyer; Charles Schneider; Ursina Teitelbaum; Katherine L. Nathanson; Susan M. Domchek; Kim A. Reiss: A Retrospective Survival Analysis of Patients with Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation JCO Precision Oncology : 2019.
Ben Boursi, Einat shacham-Shmueli, Yaacov Richard Lawrence, Yu-Xiao Yang, Kim Anna Reiss, Talia Golan, Raashi Mamtani, Naama Halpern, Dan Aderka, Bruce Giantonio, Ofer Margalit: Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer with Mutated KRAS ASCO GI, San Francisco, CA : 2019.
Kim A. Reiss, MD; Edgar Ben-Josef, MD; Nevena Damjanov, MD; Maarouf Hoteit, MD; Thomas Karasic, MD; Erica Carpenter, PhD; Lisa DiCicco, RN; Luis Garica-Marcano, MD; Rosemarie Mick, MS; Robert H. Vonderheide, MD, PhD: A pilot study of galunisertib (LY2157299 monohydrate) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC) ASCO GI Meeting, San Francisco, CA : 2019.